NeoStem, Inc. Awarded Second Year of National Institute of Allergy...

NeoStem, Inc. , a leader in the emerging cellular therapy industry, today announced that it has been awarded the second year of a two year grant totaling $595,252 for the "Development of Human, Autologous, Pluripotent Very Small Embryonic Like Stem Cells as a Countermeasure to Radiation Threat", Grant Number 5R43AI098325-02 from the National ... (more)

http://www.biospace.com/news_story.aspx?StoryID=291856&full=1